美国总统特朗普政府据称正在考虑加强对制药广告的监管。

Core Viewpoint - The Trump administration is reportedly considering increasing regulations on pharmaceutical advertising [1] Group 1 - The potential regulatory changes could impact how pharmaceutical companies market their products [1] - Increased scrutiny on drug advertisements may lead to a shift in marketing strategies within the pharmaceutical industry [1] - The move reflects ongoing concerns about the transparency and ethics of drug marketing practices [1]